First Quarter 2008 - Issues in Hematology - ION Solutions

More documents

Recommendations

Info

eimbursement watchoncologistics volume 7, issue 1 - spring 2008 24STAYING ON TOP OF MAC-RELATED DEVELOPMENTS WILL BE IMPORTANTAS EACH JURISDICTION STARTS TRANSITION ACTIVITIES. BEING AWAREOF JURISDICTION-SPECIFIC TIMELINES RELATED TO LOCAL CONTRACTORTRANSITION DATES AND POLICY CHANGES WILL HELP TO ENSUREAPPROPRIATE AND TIMELY CLAIMS PAYMENT.
oncologistics reimbursement watchTHE IMPACT OFMEDICARE ADMINISTRATIVECONTRACTOR REFORM ONPHYSICIAN PRACTICESby: Emily PhillipsIn the next 2 years, oncology and hematology practices across the United Stateswill experience dramatic changes in their regional Medicare contractors’ operationalrequirements, claims processing, and coverage policies. Yet with this rapidtransformation already starting, few healthcare providers have given much thoughtto the impact Medicare Administrative Contractor (MAC) reform will have on theirpractices. Providers who fail to take notice of these important changes could see claimdenials, payment delays, or missed opportunities to weigh in on proposals for newcoverage policies that could impact patient care.BACKGROUNDMAC reform is part of the Medicare ModernizationAct (MMA) of 2003, which was passed byCongress in an effort to stem rising Medicarecosts. Under MAC reform, Medicare carriers andfi scal intermediaries will be replaced by 15 PartA/B MACs divided into multi-state jurisdictions.Prior to MAC reform, there were nearly 50operational Medicare fi scal intermediaries andcarriers operating across the United States. Theend result of MAC reform will be one contractorper jurisdiction. The goal is to simplify the numberof Medicare processes and requirements onthe local level through consolidation of multipleMedicare administrators. The transitions, whichstarted in 2006 with the award for J3 to Noridian,and most recently, in J4 and J5, are intendedto improve the consistency of coverage andclaims processing requirements. Previously,CMS contracted with nearly 50 private insurersto process Medicare claims and administerMedicare benefi ts. That ultimately hamperedMedicare’s ability to meet healthcare deliverychallenges. Some issues with the formerMedicare contracting structure included a lack ofcompetition, specialization restrictions, separateprocessing for Part A and B claims, and anabsence of performance-based incentives.oncologistics 25
Page 2 and 3: C O M I N G S O O NfromCEPHALON ONC
Page 4 and 5: © 2007 Bristol-Myers Squibb Compan
Page 6 and 7: industry insightHOSPIRA’S INCREAS
Page 8 and 9: industry insightWhat core competenc
Page 10 and 11: industry insightWhat differentiates
Page 12 and 13: XELODAEfficacy that makes a differe
Page 14 and 15: Brief summary of prescribing inform
Page 16 and 17: oncologistics volume 7, issue 1 - s
Page 20 and 21: IV IRON SUPPORTTHROUGHOUT CHEMOTHER
Page 22 and 23: established, and the test dose has
Page 26 and 27: eimbursement watch14236132158151241
Page 28 and 29: eimbursement watchon a coverage top
Page 30 and 31: drug updateTHESE STUDIESDEMONSTRATE
Page 32 and 33: drug updateoncologistics volume 7,
Page 34 and 35: POWER ANDPERFORMANCEVIDAZA hits MDS
Page 36 and 37: drug updateBased on recent findings
Page 38 and 39: drug updatehad been met. Median OS
Page 40 and 41: drug update(PDGF-ß), FLT-3, RET, a
Page 42 and 43: FURTHER PROGRESS IN THE TREATMENT O
Page 46 and 47: nurse’s forumOUTPATIENT MANAGEMEN
Page 48 and 49: nurse’s forumoncologistics volume
Page 50 and 51: oncologistics eye on ionEYE on IONG
Page 52 and 53: Note for printer: NOVARTIS 2PG INSE
Page 55 and 56: “ ION provides me with a better v

First Quarter 2008 - Issues in Hematology - ION Solutions

Create successful ePaper yourself

Delete template?

Save as template?